Our Partnered Products

Products Approved for Our Partners in Other Countries

Nifedipine Extended-release 30 mg and 60 mg







Venlafaxine Extended-release Tablets 37.5 mg, 75 mg & 150 Mg









Oxybutynin Extended-release Tablets 5 mg, 10 mg, & 15 mg









Loratadine 10 mg combo with Pseudoephedrine Extended-release Tablets 240 mg



Theophylline Extended-release Tablets 400 mg



Pseudoephedrine Extended-release Tablets 240 mg




Osmolagrimas - Sterile Ophthalmic Solution

OVERVIEW OUR BUSINESS OUR HISTORY OUR LOCATIONS DEVELOPMENT FACILITIES OUR MANAGEMENT TEAM OUR BOARD OF DIRECTORS OUR INVESTORS OUR EMPLOYEES WHAT'S NEW OVERVIEW PARTNERING WITH OSMOTICA OUT-LICENSING OPPORTUNITIES IN-LICENSING INTERESTS PROJECT MANAGEMENT OVERVIEW OSMODEX FAMILY OTHER TECHNOLOGIES INTELLECTUAL PROPERTY R&D STRATEGY NEUROLOGY PIPELINE PARTNERED PIPELINE TECHNOLOGY PIPELINE SCIENTIFIC ADVISORY BOARD LICENSED PRODUCTS APPROVED IN U.S. APPROVED IN OTHER COUNTRIES CONTACT US

Version 8 October 6, 2009 | Copyright © 2009 Osmotica Pharmaceutical Corp., All rights reserved. | Terms and Conditions